Laurus Labs Limited — Important, 26-06-2025: General Updates
26-06-2025 | 11:54 am
26-06-2025 | 11:54 am
Laurus Labs has invested ₹39.99 Cr in its subsidiary Laurus Bio by acquiring 15,414 Series A2 Compulsorily Convertible Preference Shares through a private placement at a substantial premium. This strategic infusion strengthens Laurus Bio’s capital base, supporting its growth initiatives in the biotech segment.
No comments yet. Be the first to comment!
